Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Tumor-Agnostic 5 CNS 5 Head & Neck 2 Sarcoma 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Urinary Bladder Neoplasms 13 Prostatic Neoplasms 11 Kidney Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Wilms Tumor 2 Carcinoma, Renal Cell 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Prostate CA 1 Prostate Adenocarcinoma 1 Pain, Postoperative 1 Pain 1 Ovarian Germ Cell Cancer 1 Oligometastatic Renal Cell Carcinoma 1 Neoplasms, Second Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer 1 Lung Neoplasms 1 Endodermal Sinus Tumor 1 Directly Observed Therapy 1 Carcinoma, Transitional Cell 1 Adenocarcinoma 1 Acute Kidney Injury 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 14 Paclitaxel 13 Prednisone 11 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 atezolizumab 6 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 cemiplimab 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Surgical Procedures, Operative × Genitourinary × Clear all

NCT00491621 2015-06-04

CMM

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Kidney Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡